Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment

Lancet Oncol. 2005 Aug;6(8):552-3. doi: 10.1016/s1470-2045(05)70273-4.
No abstract available

MeSH terms

  • Animals
  • Contraceptives, Oral, Hormonal / adverse effects*
  • Estrogens / adverse effects
  • Estrogens / therapeutic use
  • Female
  • Hormone Replacement Therapy / adverse effects*
  • Humans
  • Menopause
  • Neoplasms / chemically induced*
  • Neoplasms / prevention & control
  • Progestins / adverse effects
  • Progestins / therapeutic use
  • Risk Factors

Substances

  • Contraceptives, Oral, Hormonal
  • Estrogens
  • Progestins